SCHEMBL7010359

SCHEMBL7010359

O=c1[nH]c(-c2ccccc2)cn1C1CC[N]CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.62
DRD4 P21917 1/20 0.62
DRD3 P35462 1/20 0.62
TNKS O95271 1/20 0.47
CALCRL Q16602 12/20 0.44
CCR5 P51681 1/20 0.44
KCNH2 Q12809 1/20 0.44
RAMP1 O60894 2/20 0.42
AKT1 P31749 1/20 0.40
ERCC1 P07992 1/20 0.39
FEN1 P39748 1/20 0.39
ERCC4 Q92889 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CTSS P25774 1/20 0.37
NPC1 O15118 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5551325 0.84 DRD2 (0.64) DRD2DRD4DRD3TNKSCALCRL
Hydrochloric Acid SCHEMBL2273497 0.84 DRD2 (0.64) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL2102005 0.84 DRD2 (0.64) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL10316244 0.81 DRD2 (0.68) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL3962522 0.81 DRD2 (0.61) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL12400701 0.81 DRD2 (0.72) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL13801273 0.80 DRD2 (0.67) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL2099353 0.79 DRD2 (0.65) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL14046376 0.78 DRD2 (0.75) DRD2DRD4DRD3TNKSCALCRL
SCHEMBL12372809 0.78 DRD2 (0.64) DRD2DRD4DRD3TNKSCALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163239-B1 MODIFIED AMINO-ACID AMIDES AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM PHARMA (DE) 2003-05-28 EP disclosed
US-6313097-B1 TREATMENT OR PROPHYLAXIS OF MIGRAINE OR CLUSTER HEADACHES, NON-INSULIN-DEPENDENT DIABETES MELLITUS, INFLAMMATION, ALLERGIC RHINITIS, ASTHMA, MORPHINE TOLERANCE, MENOPAUSAL HOT FLASHES, DISEASES CHARACTERIZED BY EXCESSIVE VASODILATATION BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-11-06 US disclosed